News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
210,546 Results
Type
Article (7148)
Company Profile (118)
Press Release (203280)
Multimedia
Podcasts (4)
Webinars (6)
Section
Business (61991)
Career Advice (438)
Deals (9476)
Drug Delivery (15)
Drug Development (28915)
Employer Resources (28)
FDA (3929)
Job Trends (5842)
News (103934)
Policy (7233)
Tag
Academia (703)
Accelerated approval (1)
Adcomms (2)
Allergies (27)
Alliances (16679)
ALS (50)
Alzheimer's disease (574)
Antibody-drug conjugate (ADC) (42)
Approvals (3960)
Artificial intelligence (65)
Autoimmune disease (12)
Automation (4)
Bankruptcy (50)
Best Places to Work (5333)
BIOSECURE Act (14)
Biosimilars (13)
Biotechnology (102)
Bladder cancer (36)
Brain cancer (8)
Breast cancer (114)
Cancer (882)
Cardiovascular disease (45)
Career advice (378)
Career pathing (5)
CAR-T (66)
Cell therapy (195)
Cervical cancer (7)
Clinical research (24016)
Collaboration (334)
Compensation (174)
Complete response letters (3)
COVID-19 (719)
CRISPR (14)
C-suite (118)
Cystic fibrosis (43)
Data (937)
Denatured (1)
Depression (11)
Diabetes (82)
Diagnostics (1852)
Digital health (4)
Diversity (1)
Diversity, equity & inclusion (12)
Drug discovery (50)
Drug pricing (7)
Drug shortages (3)
Duchenne muscular dystrophy (24)
Earnings (21086)
Editorial (6)
Employer resources (26)
Events (41034)
Executive appointments (321)
FDA (4331)
Frontotemporal dementia (5)
Funding (270)
Gene editing (34)
Generative AI (5)
Gene therapy (116)
GLP-1 (178)
Government (878)
Grass and pollen (1)
Guidances (20)
Healthcare (5691)
Huntington's disease (7)
IgA nephropathy (11)
Immunology and inflammation (31)
Indications (12)
Infectious disease (766)
Inflammatory bowel disease (68)
Inflation Reduction Act (1)
Influenza (18)
Intellectual property (46)
Interviews (55)
IPO (4942)
IRA (5)
Job creations (801)
Job search strategy (353)
Kidney cancer (7)
Labor market (10)
Layoffs (50)
Legal (1285)
Liver cancer (28)
Lung cancer (90)
Lymphoma (77)
Machine learning (1)
Management (7)
Manufacturing (111)
MASH (15)
Medical device (2383)
Medtech (2383)
Mergers & acquisitions (4795)
Metabolic disorders (194)
Multiple sclerosis (44)
NASH (2)
Neurodegenerative disease (21)
Neuropsychiatric disorders (5)
Neuroscience (785)
NextGen: Class of 2025 (1878)
Non-profit (1775)
Now hiring (6)
Obesity (94)
Opinion (51)
Ovarian cancer (47)
Pain (33)
Pancreatic cancer (39)
Parkinson's disease (62)
Partnered (7)
Patents (70)
Patient recruitment (39)
Peanut (19)
People (21647)
Pharmaceutical (16)
Pharmacy benefit managers (1)
Phase I (7848)
Phase II (10711)
Phase III (7723)
Pipeline (448)
Policy (31)
Postmarket research (646)
Preclinical (3184)
Press Release (51)
Prostate cancer (40)
Psychedelics (2)
Radiopharmaceuticals (90)
Rare diseases (120)
Real estate (1853)
Recruiting (13)
Regulatory (5611)
Reports (13)
Research institute (790)
Resumes & cover letters (51)
Rett syndrome (1)
RNA editing (2)
RSV (9)
Schizophrenia (27)
Series A (43)
Series B (32)
Service/supplier (3)
Sickle cell disease (17)
Special edition (1)
Spinal muscular atrophy (54)
Sponsored (7)
Startups (1161)
State (1)
Stomach cancer (2)
Supply chain (22)
Tariffs (8)
The Weekly (3)
Vaccines (137)
Venture capitalists (8)
Weight loss (41)
Women's health (8)
Worklife (2)
Date
Today (57)
Last 7 days (334)
Last 30 days (975)
Last 365 days (12647)
2025 (3921)
2024 (14027)
2023 (17949)
2022 (22544)
2021 (21984)
2020 (18344)
2019 (15063)
2018 (11424)
2017 (10627)
2016 (9889)
2015 (10711)
2014 (7659)
2013 (5913)
2012 (6043)
2011 (6142)
2010 (5172)
Location
Africa (216)
Alabama (33)
Alaska (2)
Arizona (39)
Arkansas (3)
Asia (11182)
Australia (2524)
California (2717)
Canada (764)
China (162)
Colorado (58)
Connecticut (99)
Delaware (44)
Europe (27124)
Florida (248)
Georgia (49)
Idaho (18)
Illinois (216)
India (7)
Indiana (158)
Iowa (2)
Japan (45)
Kansas (15)
Kentucky (2)
Louisiana (2)
Maine (3)
Maryland (284)
Massachusetts (2122)
Michigan (93)
Minnesota (123)
Missouri (11)
Montana (8)
Nebraska (5)
Nevada (10)
New Hampshire (8)
New Jersey (689)
New Mexico (6)
New York (654)
North Carolina (380)
North Dakota (5)
Northern California (1126)
Ohio (51)
Oklahoma (5)
Oregon (7)
Pennsylvania (544)
Puerto Rico (3)
Rhode Island (7)
South America (303)
South Carolina (1)
South Dakota (1)
Southern California (1080)
Tennessee (18)
Texas (328)
United States (9226)
Utah (55)
Virginia (27)
Washington D.C. (13)
Washington State (394)
West Virginia (1)
Wisconsin (17)
210,546 Results for "twi biotechnology".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Pharm Country
TWi Biotechnology Exploring Promising Treatment for Granuloma Annulare (GA)
TWi Biotechnology, a clinical stage biopharmaceutical company specializing in development of repositioned drugs for unmet medical needs, is currently seeking participants for a Phase 1 clinical trial of a topical gel called tofacitinib for the treatment of granuloma annulare.
June 2, 2023
·
3 min read
Press Releases
Spiderwort Biotechnologies Inc. Announces Status of Biocompatibility Testing for CelluJuve®
April 30, 2025
·
3 min read
Press Releases
Adaptive Biotechnologies Reports First Quarter 2025 Financial Results
May 1, 2025
·
13 min read
Press Releases
Nautilus Biotechnology Reports First Quarter 2025 Financial Results
April 30, 2025
·
8 min read
Press Releases
New tool for cutting DNA: promising prospects for biotechnology
April 15, 2025
·
4 min read
Press Releases
Momentum Biotechnologies Announces Acquisition of OmicScouts
March 5, 2025
·
4 min read
Press Releases
Puma Biotechnology Presents Clinical Data on Neratinib at the AACR Annual Meeting 2025
April 28, 2025
·
6 min read
Press Releases
Puma Biotechnology to Host Conference Call to Discuss First Quarter 2025 Financial Results
April 25, 2025
·
2 min read
Press Releases
UNITY Biotechnology, Inc. Reports First Quarter 2025 Financial Results and Business Updates
April 23, 2025
·
6 min read
Press Releases
Nautilus Biotechnology to Announce First Quarter 2025 Financial Results on April 29, 2025
April 16, 2025
·
1 min read
1 of 21,055
Next
